Peripheral vasoactivity in familial hypercholesterolemic subjects treated with heparin-induced extracorporeal LDL precipitation (HELP)

Atherosclerosis

Volumn 128, Issue 2, 1997, Pages 241-249

  Stadler, Robert W ^a,b   Ibrahim, Sherrif F ^a   Lees, Robert S ^a,b  

^a Boston Heart Foundation   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

apheresis; atherosclerosis; endothelium derived relaxing factor; hypercholesterolemia; ultrasound

Indexed keywords

HEPARIN;

ADULT; APHERESIS; ARTICLE; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; ULTRASOUND;

ADULT; BLOOD COMPONENT REMOVAL; BRACHIAL ARTERY; CHOLESTEROL, LDL; FEMALE; HEPARIN; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; REFERENCE VALUES; VASOMOTOR SYSTEM;

EID: 0031052159     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(96)05998-9     Document Type: Article

References (29)

1. Armstrong VW, Windisch M, Wieland H et al. Selective continuous elimination of low density lipoproteins with heparin at acidic pH. Trans Am Soc Artif Intern Organs 1983;29:323-327.
2. Eisenhauer T, Armstrong VW, Wieland H, Fuchs C, Scheler F, Seidel D. Selective removal of low density lipoproteins (LDL) by precipitation at low pH: first clinical application of the HELP system. Klin Wochenschr 1987;65:161-168.
3. Seidel D, Armstrong VW, Schuff-Werner P, Eisenhauer T. Removal of low-density lipoproteins (LDL) and fibrinogen by precipitation with heparin at low pH: clinical application and experience. J Clin Apheresis 1988;4:78-81.
4. Lane DM, Alaupovic P, Knight-Gibson C, Dudley VS, Laughlin LO. Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein (HELP) treatments. Am J Cardiol 1995;75:1124-1129.
5. Seidel D, Armstrong VW, Schuff-Werner P, and the HELP study group. The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of heart disease. I. Evaluation of safety and cholesterol-lowering effects during the first 12 months. Eur J Clin Invest 1991;24:375-383.
6. Schuff-Werner P, Gohlke H, Bartmann U et al. The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. Eur J Clin Invest 1994;24:724-732.
7. Hennerici M, Kleophas W, Gries FA. Regression of carotid plaques during low density lipoprotein cholesterol elimination. Stroke 1991;22:989-992.
8. Thiery J, Walli AK, Janning G, Seidel D. Low-density lipoprotein plasmapheresis with and without lovastatin in the treatment of the homozygous form of familial hypercholesterolemia. Eur J Pediatr 1990;149:716-721.
9. Zwiener RJ, Uauy R, Petruska ML, Huet BA. Low-density lipoprotein apheresis as long-term treatment for children with homozygous familial hypercholesterolemia. J Pediatr 1995;126:728-735.
10. Vita JA, Treasure CB, Nabel EG et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990;81:491-497.
11. Drexler H, Zeiher AM. Endothelial function in human coronary arteries in vivo. Focus on hypercholesterolemia. Hypertension 1991;18(4 Suppl):II90-II99.
12. Filitti V, Giral P, Simon A, Merli I, Del Pino M, Levenson J. Enhanced constriction of the peripheral large artery in response to acute induction of a low flow state in human hypercholesterolemia. Arterioscler Thromb 1991;11:161-166.
13. Celermajer DS, Sorensen KE, Gooch VM et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-1115.
14. Harrison DG, Armstrong ML, Freiman PC, Heistad DD. Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest 1987;80:1808-1811.
15. Leung W-H, Lau C-P, Wong C-K. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet 1993;341:1496-1500.
16. Egashira K, Hirooka Y, Kai H et al. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 1994;89:2519-2524.
17. Treasure CB, Klein JL, Weintraub WS et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995;332:481-487.
18. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995;332:488-493.
19. Vogel RA, Corretti MC, Plotnick GD. Changes in flow-mediated brachial arterial vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men. Am J Cardiol 1996;77:37-40.
20. Sorensen KE, Celermajer DS, Spiegelhalter DJ et al. Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. Br Heart J 1995;74:247-253.
21. Stadler RW, Karl WC, Lees RS. New methods for arterial diameter measurement from B-mode images. Ultrasound Med Biol 1996;22:25-34.
22. Stadler RW, Ibrahim SF, Lees RS. Measurement of the time course of pheripheral vasoactivity: results in cigarette smokers. Submitted for publication.
23. Hatch FT, Lees RS. Practical methods for plasma lipoprotein analysis. Adv Lipid Res 1968;6:1-68.
24. Friedewald WT, Levy RI, Friedrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparation ultracentrifuge. Clin Chem 1972;18:499-502.
25. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994;24:1468-1374.
26. Sorensen KE, Celermajer DS, Georgakopoulos D, Hatcher G, Betteridge DJ, Deanfield JE. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein (a) level. J Clin Invest 1994;93:50-55.
27. Arcaro G, Zenere BM, Travia D et al. Non-invasive detection of early endothelial dysfunction in hypercholesterolemic subjects. Atherosclerosis 1995;114:247-254.
28. Singh S. Response of digital arteries of endothelium dependent and endependent vasodilators in patients with Raynaud's phenomenon. Eur J Clin Invest 1995;25:182-185.
29. Yamane K. Endothelin and collagen vascular disease: a review with special reference to Raynaud's phenomenon and systemic sclerosis. Internal Med 1994;33:579-582.